QUARTERLY FINANCIAL DATA Unaudited Quarterly Financial Data (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 |
Dec. 31, 2018 |
Sep. 28, 2018 |
Jun. 29, 2018 |
Mar. 31, 2018 |
Dec. 31, 2017 |
Sep. 29, 2017 |
Jun. 30, 2017 |
Mar. 31, 2019 |
Mar. 31, 2018 |
Mar. 31, 2017 |
|
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
| Net sales | $ 6,226,124 | $ 6,922,827 | $ 6,662,604 | $ 6,398,956 | $ 6,410,887 | $ 6,751,552 | $ 6,270,420 | $ 6,008,272 | $ 26,210,511 | $ 25,441,131 | $ 23,862,934 |
| Gross profit | 380,295 | 357,325 | 402,301 | 377,854 | 349,297 | 446,328 | 393,325 | 406,932 | 1,517,775 | 1,595,882 | 1,520,945 |
| Net income (loss) | $ (64,352) | $ (45,169) | $ 86,885 | $ 116,035 | $ (19,595) | $ 118,333 | $ 205,086 | $ 124,710 | $ 93,399 | $ 420,961 | $ 311,072 |
| Net income (loss): | |||||||||||
| Basic (in dollars per share) | $ (0.12) | $ (0.09) | $ 0.16 | $ 0.22 | $ (0.04) | $ 0.22 | $ 0.39 | $ 0.24 | $ 0.18 | $ 0.81 | $ 0.59 |
| Diluted (in dollars per share) | $ (0.12) | $ (0.09) | $ 0.16 | $ 0.22 | $ (0.04) | $ 0.22 | $ 0.38 | $ 0.23 | $ 0.18 | $ 0.80 | $ 0.59 |
| Restructuring charges | $ 65,800 | $ 82,700 | $ 99,005 | $ 66,845 | $ 38,758 | ||||||
| Inventory impairment and other | 70,000 | 93,000 | |||||||||
| Gain on sale | $ 91,800 | 0 | (38,689) | 7,400 | |||||||
| Gain on deconsolidation | 86,614 | 151,574 | 0 | ||||||||
| Cost of sales | |||||||||||
| Net income (loss): | |||||||||||
| Restructuring charges | 60,400 | 58,900 | $ 99,000 | $ 66,800 | $ 38,800 | ||||||
| Selling, general and administrative expenses | |||||||||||
| Net income (loss): | |||||||||||
| Restructuring charges | 5,400 | $ 23,800 | |||||||||
| Wink Labs Inc | |||||||||||
| Net income (loss): | |||||||||||
| Gain on sale | $ 38,700 | ||||||||||
| Elementum | |||||||||||
| Net income (loss): | |||||||||||
| Inventory impairment and other | $ 84,000 | ||||||||||
| Gain on deconsolidation | $ 151,600 | ||||||||||
| Accounting Standards Update 2014-09 | |||||||||||
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
| Net sales | $ 22,000 | $ 48,000 | $ 25,000 | ||||||||